medigraphic.com
Colegio de Medicina Interna de México.

2015, Number 1

<< Back Next >>

Med Int Mex 2015; 31 (1)

Emerging infectious diseases and blood donation

Gutiérrez-Salinas J, Mondragón-Terán P, García-Ortíz L, Pérez-Razo JC, Hernández-Rodríguez S, Ramírez-García S, Núñez-Ramos NR

Language: Spanish
References: 29
Page: 77-86
PDF size: 437.53 Kb.


ABSTRACT

Emerging infectious diseases include diseases of known or unknown infectious origin, which incidence in humans has increased in the last two decades or threatens to increase in the near future. The type of pathogen, host, vector and environment are the main causes related to the increase in incidence of infectious diseases. It is widely known that an emergent pathogen in the incubation period could be a potential risk in the process of blood transfusion; mainly if there is not an available technology for its appropriate detection as it may include mutated strains of well-known pathogens. International agencies work closely with research laboratories in order to develop new and more sensitive diagnostic methods and systems to make possible the detection and control on time of these emerging diseases. Specialists of local blood banks work with regionalized population, providing a wide opportunity to detect these pathogens; this system allows a rapid detection of the probable region of origin of the disease. Emerging infectious diseases result in serious medical and socio-economic impacts, hence sanitary authorities, political control systems, and international agencies should work in collaboration to control the outbreak and avoid a global impact.


REFERENCES

  1. Daszak P. Cunningham AA. Anthropogenic change, biodiversity loss, and a new agenda for emerging diseases. J Parasitol 2003;89:37-41.

  2. Brown C. Emerging zoonoses and pathogens of public health significance. An overview. Rev Sci Tech 2004;23:435-442.

  3. Stramer SL, Blaine FH, Katz ML, Kleinman S, et al. Emerging infectious disease agents and their potential threat to transfusion safety. Transfusion 2009;49:1-29.

  4. Yale G, Bhanurekha V, Ganesan PI. Anthropogenic factors responsible for emerging and re-emerging infectious diseases. Current Sci 2013;105:940-946.

  5. Desselberger U. Emerging and re-emerging infectious diseases. J Infect 2000;40:3-15.

  6. Morse SS. Factors in the emergence of infectious diseases. Emerg Infect Dis 1995;1:7-15.

  7. Bengis RG, Leighton FA, Fischer JR, Artois M, et al. The role of wildlife in emerging and re-emerging zoonoses. Rev Sci Tech 2004;23:497-511.

  8. Wolfe ND, Dunavan CP, Diamond J. Origins of major human infectious diseases. Nature 2007;447:279-283.

  9. Morens DM, Folkers GK, Fauci AS. Emerging infections: a perpetual challenge. Lancet Infect Dis 2008;8:710-719.

  10. Tsetsarkin KA, Vanlandingham DL, McGee CE, Higgs S. A single mutation in chikungunya virus affects vector specificity and epidemic potential. PLoS Pathogens 2007;3:201.

  11. Dodd RY. Emerging pathogens and their implications for the blood supply and transfusion transmitted infections. Brith J Haematol 2012;159:135-142.

  12. Jones K. Global trends in emergin infectious diseases. Nature 2008;451:990-993.

  13. Mendoza C, Altisent C, Aznar JA, Batlle J, Soriano V. Emergin viral infections–a potential threat for blood suppy in the 21st century. AIDS Rev 2012;14:279-289.

  14. Alter H, Stramer S, Dood R. Emerging infectious diseases that threaten the blood supply. Semin Hematol 2007;44:32- 41.

  15. Trimble SR, Parker CS, Grant AM, Soucie JM, Reyes N. Assessing emerging infectious threats to blood safety for the blood disorders community. Am J Prev Med 2010;38:468-474.

  16. Ceccherini-Nelli L, Filipponi F, Mosca F, Campa M. The risk of contracting and infectious disease from blood transfusion. Transplant Proc 2004;36:680-682.

  17. Busch MP, Glynn SA, Stramer SL, Strong DM, et al. A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors. Transfusion 2005;45:254-264.

  18. Bernardin F, Operskalski E, Busch M, Delwart E. Transfusion transmission of highly prevalent commensal human viruses. Transfusion 2010;50:2474-2483.

  19. Lipkin WI. Microbe hunting. Microbiol Mol Biol Rev 2012;74:363-377.

  20. Cameron PA, Rainer TH. Update on emerging infections: News from the Centers for Disease Control and Prevention. Ann Emerg Med 2003;42:113-116.

  21. Ambriz-Fernández R. Enfermedades infecciosas emergentes. Gac Méd Méx 2004;140:82-85.

  22. Dodd RY. Current risk for transfusion transmitted infections. Curr Opin Hematol 2007;14:671-676.

  23. Dodd RY. Emerging infections, transfusion safety, and epidemiology. N Engl J Med 2003;349:1205-1206.

  24. Blejer JL, Carreras LAV, Salamone HJ. Riesgo de transmisión de infecciones por vía transfusional. Medicina (B Aires) 2002;62:259-278.

  25. Hashimoto S, Murakami Y, Taniguchi K, Nagai M. Detection of epidemics in their early stage through infectious disease surveillance. Int J Epidem 2000;29:905-910.

  26. Wagner MM, Tsui FC, Espino JU, Dato VM, et al. The emerging science of very early detection of disease outbreaks. J Public Health Manag Pract 2001;7:51-59.

  27. Effler P, Ching-Lee M, Bogard A, Man-Cheng L, et al. Statewide system of electronic notifiable disease reporting from clinical laboratories: comparing automated reporting with conventional methods. JAMA 1999;282:1845- 1850.

  28. Zyga S, Zografakis-Sfakianakis M. Emerging and re-emerging infectious diseases: A potential pandemic threat. Health Sci J 2011;5:159-168.

  29. Pérez-Padilla R, De la Rosa-Zamboni D, Ponce de Leon S, Hernández M, et al. Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. N Engl J Med 2009;361:680-689.




2020     |     www.medigraphic.com